DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

BACKGROUND: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with impaired glucose tolerance or type 2 diabetes. Dipeptidyl peptidase 4 (DPP-4) inhibitors also attenuate PPH. PPH is one of the factors leading to en...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Nakamura, Kazufumi, Oe, Hiroki, Kihara, Hajime, Shimada, Kenei, Fukuda, Shota, Watanabe, Kyoko, Takagi, Tsutomu, Yunoki, Kei, Miyoshi, Toru, Hirata, Kumiko, Yoshikawa, Junichi, Ito, Hiroshi
格式: Artigo
語言:Inglês
出版: BioMed Central 2014
主題:
Original Investigation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149239/
https://ncbi.nlm.nih.gov/pubmed/25074318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0110-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍